Home/NeuroKappa Therapeutics/Renyu Liu, MD, PhD

RL

Renyu Liu, MD, PhD

Founder

NeuroKappa Therapeutics

Therapeutic Areas

Stroke Pain Management Addiction Therapy Depression

NeuroKappa Therapeutics Pipeline

Drug	Indication	Phase
Salvinorin A Novel Analog	Stroke (Neuroprotection)	Pre-clinical
Dezocine & Associated Products	Opioid Addiction Management / Pain	Pre-clinical

Leadership Team at NeuroKappa Therapeutics

Peter Fang, MD, MS

John Grothusen, PhD

CSO (Chief Scientific Officer)

Gordon Barr, PhD

DMD (likely Director of Medicinal Chemistry)

Lei Fang, Esq, MD, PhD

Yi-yen Chen, PhD

Business Development

View full NeuroKappa Therapeutics profile